Literature DB >> 29956871

Expression analysis of extracellular microRNA in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.

Amit Kishore1, Zdenka Navratilova1, Vitezslav Kolek2, Eva Novosadova1, Klára Čépe3, Roland M du Bois4, Martin Petrek1.   

Abstract

BACKGROUND AND
OBJECTIVE: MicroRNA (miRNA) are transcriptional regulators implicated in pulmonary sarcoidosis and packaged in extracellular vesicles (EV) during cellular communication. We characterized EV and investigated miRNA expression in bronchoalveolar lavage (BAL) fluid from sarcoidosis patients.
METHODS: EV were characterized for size(s) using dynamic light scattering and transmission electron microscopy (TEM) analysis and protein markers by immunoblotting. Twelve extracellular and 5 cellular miRNA were investigated in BAL from 16 chest X-ray stage-I (CXR-I) and 17 CXR stage-II (CXR-II) sarcoidosis patients. Associations between miRNA and disease characteristics (extrapulmonary involvement, pulmonary function and BAL cell profile) were statistically analysed.
RESULTS: BAL from sarcoidosis patients contained exosomes and microvesicles (MV) as EV. In these EV, expression of miR-146a (P = 0.007), miR-150 (P = 0.003) and BAL cellular miR-21 (P = 0.01) was increased in CXR-II compared with CXR-I. Other detected EV (miR-21 and miR-26a) and cellular (miR-31, miR-129-3p, miR-146a and miR-452) miRNA were not differentially expressed. The investigated miRNA did not reflect extrapulmonary involvement, but EV miR-146a and miR-150 were negatively correlated with pulmonary function (miR-146a with vital capacity (VC; Spearman's correlation coefficient (rs ), P = -0.657, 0.007), percent predicted forced expiratory volume in 1 s (FEV1 ; -0.662, 0.006) and FEV1 /forced vital capacity (FVC) ratio (-0.649, 0.008); miR-150 correlated negatively with VC (-0.584, 0.019) and FEV1 /FVC ratio (-0.746, 0.001) in CXR-II cases).
CONCLUSION: Our data provide evidence that exosomes and microvesicles as extracellular vesicles are present in the bronchoalveolar space of sarcoidosis patients and they differentially express EV miRNA (miR-146a and miR-150), the expression of which correlates negatively with pulmonary function indices. The significance of these findings for disease pathophysiology and clinical course require further investigation.
© 2018 Asian Pacific Society of Respirology.

Entities:  

Keywords:  bronchoalveolar lavage; exosomes; microRNA; microvesicles; pulmonary sarcoidosis

Mesh:

Substances:

Year:  2018        PMID: 29956871     DOI: 10.1111/resp.13364

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  11 in total

Review 1.  Molecular profiling in sarcoidosis.

Authors:  Nicholas K Arger; Brian O'Connor; Laura L Koth
Journal:  Curr Opin Pulm Med       Date:  2020-09       Impact factor: 3.155

2.  Whole-exome sequencing identifies rare genetic variations in German families with pulmonary sarcoidosis.

Authors:  Amit Kishore; Britt-Sabina Petersen; Marcel Nutsua; Joachim Müller-Quernheim; Andre Franke; Annegret Fischer; Stefan Schreiber; Martin Petrek
Journal:  Hum Genet       Date:  2018-07-27       Impact factor: 4.132

Review 3.  The role of exosomes from BALF in lung disease.

Authors:  Ziyu Liu; Jiaqing Yan; Lingling Tong; Shouyue Liu; Ying Zhang
Journal:  J Cell Physiol       Date:  2021-08-13       Impact factor: 6.513

4.  Identifying and Exploiting Potential miRNA-Disease Associations With Neighborhood Regularized Logistic Matrix Factorization.

Authors:  Bin-Sheng He; Jia Qu; Qi Zhao
Journal:  Front Genet       Date:  2018-08-07       Impact factor: 4.599

Review 5.  Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?

Authors:  Artur Słomka; Sabine Katharina Urban; Veronika Lukacs-Kornek; Ewa Żekanowska; Miroslaw Kornek
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

Review 6.  microRNA exchange via extracellular vesicles in cancer.

Authors:  Luyen Tien Vu; Jinhua Gong; Thach Tuan Pham; Yeokyeong Kim; Minh T N Le
Journal:  Cell Prolif       Date:  2020-10-06       Impact factor: 6.831

Review 7.  EVs from BALF-Mediators of Inflammation and Potential Biomarkers in Lung Diseases.

Authors:  Lukasz Zareba; Jacek Szymanski; Zuzanna Homoncik; Malgorzata Czystowska-Kuzmicz
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

8.  Bronchoalveolar Lavage-microRNAs Are Potential Novel Biomarkers of Outcome After Lung Transplantation.

Authors:  Alessandro Palleschi; Gabriella Gaudioso; Valeria Edefonti; Valeria Musso; Andrea Terrasi; Federico Ambrogi; Sara Franzi; Lorenzo Rosso; Paolo Tarsia; Letizia C Morlacchi; Stefano Ferrero; Mario Nosotti; Valentina Vaira
Journal:  Transplant Direct       Date:  2020-04-09

Review 9.  Extracellular Vesicles as Mediators of Cellular Cross Talk in the Lung Microenvironment.

Authors:  Sabine Bartel; Jessy Deshane; Tom Wilkinson; Susanne Gabrielsson
Journal:  Front Med (Lausanne)       Date:  2020-08-04

10.  Evaluation of RNA isolation methods for microRNA quantification in a range of clinical biofluids.

Authors:  Henk P Roest; Jan N M IJzermans; Luc J W van der Laan
Journal:  BMC Biotechnol       Date:  2021-08-06       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.